-
Recent Posts:
Recent Comments:
Latest PLoG Posts
- Cultural Comic Books for Educating Asian Americans about Hepatitis B in Work In Progress
- Empathy and Risk Assessment in Work In Progress
- Demonstrating Progress: Building a More Equitable Global R&D System in Work In Progress
- This Week in PLOS NTD and PLOS Pathogens: Plant-Virus Ecology; a Genomic Strategy Against P. falciparum; Protective Sand Fly Saliva Proteins; and More in Work In Progress
- Violence Against Women: Implications for our communities, our world and our future in Work In Progress
You may also be interested in:

Click to go to this PLOS Medicine collection
Category Archives: Drug Development
How Much Money Do Drug Companies Pay the FDA?
Category: Drug Development, Housekeeping
Tagged FDA, NDA, new drug application, PDUFA, Prescription Drug User Fee Act
2 Comments
Protons, Electrons, and Hepatitis C
Category: Drug Development, Hepatitis C
Tagged boceprevir, cyclophilin antagonists, David Goldstein, David Thomas, Egypt, ELECTRON, FISSION, HCV, HCV genotypes, hepatitis C, Ian Lipkin, Ira Jacobson, nonnucleoside polymerase inhibitors, nucleoside polymerase inhibitors, Oliver Pybus, Pharmasset, POSITRON, protease inhibitors, PROTON, PSI-1977, telaprevir
2 Comments
Helping People. Working System?
Category: cancer, Clinical Trials, Drug Development
Tagged INC424, Incyte, myelofibrosis, Novartis, Pfizer, polycythemia vera, rheumatoid arthritis, tasocitinib, tofacitinib
3 Comments


Jessica Wapner is a freelance writer focused mainly on biomedical issues. Her work is published in Scientific American, The New York Times, Slate, Science, Nature Medicine, and elsewhere. Her first book, The Philadelphia Chromosome is forthcoming from The Experiment in May 2013.